Peer-reviewedCC BYActa Obstetricia et Gynecologica Scandinavica
Screening strategy versus drug efficacy: Revisiting the evidence for vaginal progesterone in short cervix
- 1Centre Medical du Chateaux Vincennes France
- 2Department of Obstetrics and Gynecology American Hospital of Paris Neuilly‐sur‐Seine France
Related
- Universal cervical length screening and vaginal progesterone: Distinguishing strategy effectiveness from treatment efficacy
- Systematic review of efficacy of hair transplantation in patients with classic lichen planopilaris and frontal fibrosing alopecia: revisiting the current evidence
- Progesterone and diabetic wound repair: an evidence-gap review of indirect preclinical findings
- Mid-Trimester Cervical Length Screening in Routine Practice: Short-Cervix Prevalence, Preterm Birth and the Shift of the Progesterone Counselling Threshold from 20 to 25 mm in a 15-Year Single-Centre Cohort of 20,168 Singleton Pregnancies
- Assessing an educational strategy to improve community health provider-led provision of cervical cancer screening services in western Kenya: A secondary analysis of the Elimisha-HPV cluster-randomized controlled trial
BibTeX
@article{boujenah2026screening,
title = {{Screening strategy versus drug efficacy: Revisiting the evidence for vaginal progesterone in short cervix}},
author = {Jeremy Boujenah and Patrick Rozenberg},
journal = {Acta Obstetricia et Gynecologica Scandinavica},
year = {2026},
month = oct,
doi = {10.1111/aogs.70323},
url = {https://doi.org/10.1111/aogs.70323},
note = {CC BY},
}
RIS
TY - JOUR
TI - Screening strategy versus drug efficacy: Revisiting the evidence for vaginal progesterone in short cervix
AU - Jeremy Boujenah
AU - Patrick Rozenberg
PY - 2026
DA - 2026/10/31
JO - Acta Obstetricia et Gynecologica Scandinavica
DO - 10.1111/aogs.70323
UR - https://doi.org/10.1111/aogs.70323
SN - 1600-0412
SN - 0001-6349
ER -